Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Pharmacology

Background:

• Somatostatin (SRIF) analogues are crucial for targeting various physiological processes.
• Understanding the structural basis of SRIF analogue binding to specific receptors is vital for drug development.
• Previous studies have proposed general pharmacophores for SRIF receptor subtypes (sst2/3/5).

Purpose of the Study:

• To elucidate the 3D NMR structures of novel octapeptide SRIF agonist analogues.
• To determine the structural requirements for potent and selective binding to the human SRIF type 2 (sst2) receptor.
• To compare the sst2 pharmacophore with those previously proposed for other SRIF receptor subtypes.

Main Methods:

• 3D Nuclear Magnetic Resonance (NMR) spectroscopy to determine the solution structures of six octapeptide analogues.
• Synthesis of octapeptide analogues with variations at specific positions (e.g., Xxx7).
• Correlation of structural data with biological binding assays for sst2 receptor selectivity.

Main Results:

• The backbone structures of the sst2-selective analogues adopt a type-II' beta-turn conformation.
• The side chains of DPhe2, DTrp8, and Lys9 were identified as critical for sst2 pharmacophore.
• The aromatic ring at position 7 (Phe7) is not essential for sst2 binding but is important for sst3 and sst5 binding.

Conclusions:

• The identified sst2 pharmacophore differs from previously proposed models for broader SRIF receptor subtype selectivity.
• This study provides a refined understanding of sst2 receptor recognition by SRIF analogues.
• The findings offer insights for the rational design of more selective SRIF-based therapeutics.